CXCL12 and neoplasm: In addition to mobilizing HSPC, the interference with the CXCR4-SDF1α axis has also been proposed as a possible strategy to “mobilize” malignant stem cells from their protective niche, thus rendering tumor stem cells more vulnerable to chemo- or irradiation therapy.